Biotech Values

[akasidney86]

SCLN: Assuming they achieve a 12% response rate, that would be in the worst case a 100% improvement over current treatment... nothing to sneeze at. While the actual numbers may be small, the percentage improvement is notable. As to your dismissal of the PR and the assignation of SP support as motivation, I'd suggest that there's nothing wrong with supporting the share price of ones stock with facts. I'd certainly agree with your view if they had more info that they withheld... but that's apparently not the case here. Personally, I'd be more inclined to view in that light the recent and unexplained bump in the share price of a certain company facing delisting...